ESCMID eLibrary
Search results
Icon explanation
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
-
P2783
Correlation between broth microdilution and disk diffusion methods results when testing ceftaroline against methicillin-resistant Staphylococcus aureus using the 5 microgram ceftaroline disk
16 April 2019
Session: Disk diffusion sucseptibility testing
Relevance:100% -
P1873
Antimicrobial activity of plazomicin tested against Enterobacteriaceae isolates from European medical centres stratified by infection type (2014-2017)
15 April 2019
Session: In vitro activity of newer antibacterial agents
Relevance:100% -
P1823
Antimicrobial activity of lefamulin against a large longitudinal collection of clinical bacterial isolates collected worldwide: results from the SENTRY antimicrobial surveillance program
15 April 2019
Session: In vitro activity of investigational antibacterial agents
Relevance:100% -
P1843
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide
15 April 2019
Session: New membrane-active antibiotics
Relevance:100% -
P1174
Antimicrobial activity of high-dose extended infusion cefepime-tazobactam (WCK 4282) tested against Gram-negative organisms collected from medical centres located in Europe and the Asia-Pacific region in 2018
14 April 2019
Session: New beta-lactamase inhibitors: in vitro studies
Relevance:100% -
P1199
Antimicrobial activity of cefoperazone-sulbactam against Gram-negative organisms from Europe, Asia-Pacific, and Latin America in 2015-2016
14 April 2019
Session: Tazobactam and sulbactam plus cephalosporins
Relevance:100% -
P1171
Antimicrobial activity of cefepime-zidebactam (WCK-5222) against clinical isolates of carbapenem-resistant Enterobacteriaceae collected worldwide in 2018
14 April 2019
Session: New beta-lactamase inhibitors: in vitro studies
Relevance:100% -
P1172
Cefepime-zidebactam (WCK-5222) activity when tested against Gram-negative organisms isolated from patients hospitalised in Europe and the Asia-Pacific region in 2018
14 April 2019
Session: New beta-lactamase inhibitors: in vitro studies
Relevance:100% -
P1661
Murepavadin activity tested against contemporary (2016-2017) clinical isolates of extensively drug-resistant (XDR) Pseudomonas aeruginosa
23 April 2018
Session: Membrane-active antibiotics and peptides: in vitro and in vivo activity
Relevance:100% -
P1662
Antimicrobial activity of murepavadin tested against clinical isolates of Pseudomonas aeruginosa collected in Europe, the United States and China
23 April 2018
Session: Membrane-active antibiotics and peptides: in vitro and in vivo activity
Relevance:100%
